AIT Bioscience Names CEO
Indianapolis-based contract research organization AIT Bioscience has named Jeff Goddard chief executive officer and a member of the AIT Bioscience Board of Directors. Goddard is the...... Read More
BigWigs & New Gigs: Life Sciences
Irish Research Center Hires Purdue Prof
Ireland’s National Institute for Bioprocessing Research and Training has hired Purdue's Elizabeth Topp as chief science officer. She has served as professor in the college of pharmacy...... Read More
IBRI Announces Diabetes Research Team
The Indiana Biosciences Research Institute has named Decio Eizirik (pictured) research fellow for its diabetes research center. Also, Donalyn Scheuner was recently named senior staff...... Read More
Lilly Announces Changes in Senior Leadership
Eli Lilly and Company has announced several changes to the company's executive committee. Mike Harrington (pictured), senior vice president and general counsel, will retire at the end of...... Read More
BioCrossroads Appoints Lilly Exec CEO
After a national search, BioCrossroads has announced Patty Martin will become the life science initiative's next president and chief executive officer. Martin, who most recently served...... Read More
IBRI Chief Steps Down, Takes New Role
The Indiana Biosciences Research Institute has announced Chief Executive Officer and Chief Scientific and Innovation Officer Rainer Fischer has stepped down from both roles. The...... Read More
16 Tech Adds Director of Business Development
The 16 Tech Community Corp. has named Eric Miller director of business development. He previously worked in commercial real estate in the Research Triangle Region of North Carolina for...... Read More
Springer Joins Conexus Indiana
Conexus Indiana has named Shane Springer director of industry engagement, where he will lead a statewide networked community of advanced manufacturers representing a broad range of industry...... Read More
BioCrossroads CEO Moving On
The chief executive officer of the state's life sciences initiative is stepping down. BioCrossroads says David Johnson, who has led the organization for 14 years, is leaving at the end of the year...... Read More
B2S Life Sciences Names VP
Franklin-based B2S Life Sciences LLC, a biotherapeutic drug development company, has appointed William "Bill" Nowatzke vice president of laboratory operations and clinical laboratory improvement...... Read More
AquaBounty Names New CEO
A Massachusetts-based company, with a presence in east central Indiana, has named a new chief executive officer. AquaBounty Technologies Inc. says Sylvia Wulf, who currently serves as senior...... Read More
Elanco Names Young CFO
Elanco Animal Health Inc. has named Todd Young as executive vice president and chief financial officer. He has more than 20 years of experience in a wide range of financial roles. Most recently,...... Read More
White Promoted to President of Lilly Oncology
Eli Lilly and Co. has promoted Anne White to senior vice president of Lilly and president of Lilly Oncology. She will become a member of Lilly's executive committee, reporting directly to...... Read More
Pearl Pathways Hires Business Development Director
Pearl Pathways has hired Cara Frosch as director of business development. She has more than 35 years of diversified biopharmaceutical and medical device experience in human and animal health ...... Read More
Elanco Names Hicks General Counsel
Elanco Animal Health has named Michael-Bryant Hicks general counsel. He joins the division of Eli Lilly and Co. at its Greenfield headquarters. Hicks has almost 20 years of corporate ...... Read More
AIT Bioscience Adds to Leadership Team
AIT Bioscience LLC has promoted Robyn Durr-Henry (pictured) to senior director of quality assurance. The life sciences firm has also named Mark Cameron (pictured) vice president of scientific ...... Read More
Pearl Pathways Hires Clinical Services Advisor
Pearl Pathways has hired Nancy Kant as clinical services advisor to support biopharmaceutical and diagnostic life science companies. Kant’s career includes 16 years at Eli Lilly and Co., ...... Read More
Lilly Oncology President to Retire
The president of Lilly Oncology has announced plans to retire. Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says Sue Mahony will step down from the role at the end of August after 18 years ...... Read More
Bourdage to Retire as BASi VP of Bioanalytical Operations
West Lafayette-based Bioanalytical Systems Inc. has announced James Bourdage (pictured) is retiring. He is vice president of bioanalytical operations. Michael Baim will succeed Bourdage ...... Read More
Gandhi to Lead Lilly Oncology Immuno-Oncology Medical Development
Eli Lilly and Co. has announced Leena Gandhi will join Lilly Oncology June 25 to lead immuno-oncology medical development. She is currently director of thoracic medical oncology and an ...... Read More